Price
$0.60
Decreased by -3.34%
Dollar volume (20D)
1.45 M
ADR%
11.61
Earnings report date
Aug 7, 2024
Shares float
59.80 M
Shares short
5.77 M [9.66%]
Shares outstanding
80.81 M
Market cap
49.79 M
Beta
2.41
Price/earnings
N/A
20D range
0.52 0.81
50D range
0.52 1.21
200D range
0.52 3.01

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.

The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics.

In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing.

Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 8, 24 -0.51
Decreased by -325.00%
-0.64
Increased by +20.31%
Mar 5, 24 -0.96
Decreased by -637.92%
-0.87
Decreased by -10.26%
Nov 8, 23 -1.00
Decreased by -809.09%
-0.97
Decreased by -3.09%
Aug 9, 23 -1.24
Decreased by -1.03 K%
-1.03
Decreased by -20.39%
May 9, 23 -0.12
Decreased by -9.09%
-0.11
Decreased by -9.09%
Mar 9, 23 -0.13
Decreased by -62.50%
-0.11
Decreased by -18.18%
Nov 3, 22 -0.11
Decreased by -57.14%
-0.11
Aug 4, 22 -0.11
Decreased by -83.33%
-0.09
Decreased by -22.22%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 8.77 M
Increased by +18.26%
-31.42 M
Increased by +15.36%
Decreased by -358.33%
Increased by +28.43%
Dec 31, 23 10.72 M
Increased by +30.51%
-43.89 M
Decreased by -13.48%
Decreased by -409.39%
Increased by +13.04%
Sep 30, 23 9.32 M
Increased by +29.04%
-112.57 M
Decreased by -253.88%
Decreased by -1.21 K%
Decreased by -174.24%
Jun 30, 23 8.66 M
Increased by +29.87%
-38.91 M
Decreased by -21.00%
Decreased by -449.23%
Increased by +6.82%
Mar 31, 23 7.42 M
Increased by +30.18%
-37.12 M
Decreased by -23.94%
Decreased by -500.66%
Increased by +4.79%
Dec 31, 22 8.21 M
Increased by +30.36%
-38.68 M
Decreased by -68.53%
Decreased by -470.81%
Decreased by -29.29%
Sep 30, 22 7.22 M
Increased by +55.12%
-31.81 M
Decreased by -53.27%
Decreased by -440.51%
Increased by +1.19%
Jun 30, 22 6.67 M
Increased by +72.98%
-32.16 M
Decreased by -71.18%
Decreased by -482.13%
Increased by +1.04%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY